| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $161,711,107 ) (Continued on the next page) |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322 | DEKALB | USA | R01AI144067 | dsRNA regulation of the cytosolic innate immune system | 000 | 8 | NIH | 4/28/2026 | $460,018 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322 | DEKALB | USA | F31AG099643 | Neuromelanin Formation and Toxicity in the Locus Coeruleus: The Role of Norepinephrine Metabolism | 002 | 1 | NIH | 4/1/2026 | $576 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322 | DEKALB | USA | R00HL161355 | Accumulation of stress and trauma across the life course and cardiometabolic risk during pregnancy and postpartum | 000 | 5 | NIH | 3/20/2026 | $248,915 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322 | DEKALB | USA | UM1AI069418 | Emory-CDC CTU | 003 | 20 | NIH | 4/13/2026 | $1,568,964 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322 | DEKALB | USA | R01AI174933 | Defining Sex-Specific Systemic and Gut Inflammatory Profiles in People Living with HIV | 000 | 4 | NIH | 4/8/2026 | $781,138 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322 | DEKALB | USA | R01HL168383 | Role of CEBPb in flow-dependent endothelial dysfunction and atherosclerosis | 000 | 4 | NIH | 4/8/2026 | $719,786 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322 | DEKALB | USA | R01DA059182 | Substance use in PRegnancy and the mOrbidity Mortality rISk Environment (PROMISE) | 000 | 3 | NIH | 4/8/2026 | $702,932 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322 | DEKALB | USA | R35GM143050 | MULTICOMPONENT MECHANOCHEMICAL REGULATION OF ACTIN FILAMENT END DYNAMICS | 002 | 6 | NIH | 4/29/2026 | $458,196 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322 | DEKALB | USA | R01HL166455 | Cadmium and Arsenic Effects on Pyrimidine Biosynthesis in Early Airway Development | 000 | 4 | NIH | 4/28/2026 | $391,250 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322 | DEKALB | USA | R13HD122424 | Annual Southeastern Pediatric Research Conference | 000 | 1 | NIH | 5/4/2026 | $20,000 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322 | DEKALB | USA | K22AG088144 | Preparedness for Caregiving in Experienced Caregivers of Persons Living with Dementia | 001 | 2 | NIH | 4/23/2026 | $0 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322 | DEKALB | USA | R01HL142762 | Characterization of hapln1a positive cells during zebrafish heart regeneration | 000 | 6 | NIH | 4/9/2026 | $450,374 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322 | DEKALB | USA | F32HD121287 | Uncovering the role of Importin9 in Hedgehog signaling | 002 | 1 | NIH | 4/8/2026 | $1,356 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322 | DEKALB | USA | R01AI141327 | Structural and Chemical Analysis of Highly Potent ALLINI Platform | 000 | 8 | NIH | 4/15/2026 | $473,896 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322 | DEKALB | USA | UM1AI069418 | Emory-CDC CTU | 005 | 20 | NIH | 4/15/2026 | $236,635 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322 | DEKALB | USA | K99AI190118 | Understanding Multidrug-Resistant Pathogen Infections and their Treatment with Antibiotics and Bacteriophages | 000 | 1 | NIH | 4/17/2026 | $161,244 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322 | DEKALB | USA | R01CA258857 | Targeting posttranslational modifications of CD73 in TNBCs | 000 | 6 | NIH | 4/9/2026 | $668,375 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322 | DEKALB | USA | P01HD112217 | Immune determinants of pediatric HIV/SIV reservoir establishment and maintenance | 000 | 4 | NIH | 3/30/2026 | $1,544,342 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322 | DEKALB | USA | R61AI197036 | Novel Long-Acting HBV Capsid Assembly Modulators | 000 | 1 | NIH | 4/9/2026 | $954,603 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322 | DEKALB | USA | R01MH134267 | Evaluating the effectiveness of a mobile HIV prevention app to increase HIV and STI testing and PrEP initiation among rural men who have sex with men | 000 | 4 | NIH | 4/29/2026 | $100,000 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322 | DEKALB | USA | R01MH134267 | Evaluating the effectiveness of a mobile HIV prevention app to increase HIV and STI testing and PrEP initiation among rural men who have sex with men | 000 | 4 | NIH | 4/29/2026 | $424,903 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322 | DEKALB | USA | R01MH134267 | Evaluating the effectiveness of a mobile HIV prevention app to increase HIV and STI testing and PrEP initiation among rural men who have sex with men | 000 | 4 | NIH | 4/29/2026 | $200,000 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322 | DEKALB | USA | F31NS141610 | Novelty and valence encoding in the zona incerta in parkinsonian monkeys | 001 | 2 | NIH | 4/15/2026 | $576 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322 | DEKALB | USA | F31CA278008 | The role of DPF2 stability in SMARCB1-deficient cancers | 001 | 3 | NIH | 4/16/2026 | $576 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322 | DEKALB | USA | R01ES037289 | New Statistical Methods for Estimating Health Effects of Environmental Exposures | 000 | 2 | NIH | 4/17/2026 | $502,887 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322 | DEKALB | USA | R01CA277686 | Dissecting and targeting oncogenic functions of PAK4 in high-risk rhabdomyosarcoma | 001 | 4 | NIH | 4/16/2026 | $35,649 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322 | DEKALB | USA | UM1AI069418 | Emory-CDC CTU | 004 | 20 | NIH | 4/15/2026 | $211,745 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322 | DEKALB | USA | R35GM156739 | Lipoprotein trafficking to the bacterial outer membrane | 001 | 2 | NIH | 3/11/2026 | $43,461 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322 | DEKALB | USA | R00CA277580 | Identifying factors associated with ovarian cancer recurrence using a population-based approach | 001 | 4 | NIH | 4/17/2026 | $24,800 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322 | DEKALB | USA | R01DE033433 | Targeted Arf1 inhibition to enhance immune response in oral cancer | 001 | 3 | NIH | 4/16/2026 | $37,191 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322 | DEKALB | USA | R01HL175515 | Targeting mitoNEET in pulmonary hypertension | 001 | 2 | NIH | 4/17/2026 | $17,675 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322 | DEKALB | USA | F30CA291027 | ICOS is an important mediator of both resident memory cell formation, and improved durability and persistence of anti-tumor T cells | 001 | 2 | NIH | 4/16/2026 | $576 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322 | DEKALB | USA | R38HL167243 | Emory Pediatrics and Pathology Stimulating Access to Research in Residency (Emory-PP StARR). | 001 | 4 | NIH | 4/17/2026 | $8,360 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322 | DEKALB | USA | R01CA276135 | Discovery of a novel MDM2-tubulin signaling pathway as a therapeutic target in AML | 001 | 3 | NIH | 4/16/2026 | $53,631 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322 | DEKALB | USA | R01CA287866 | Leveraging CD26high Meso-CAR T cells in patients with advanced pancreatic cancer | 001 | 3 | NIH | 4/16/2026 | $63,892 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322 | DEKALB | USA | U01CA264039 | Improved whole-brain spectroscopic MRI for radiation therapy planning | 000 | 8 | NIH | 4/17/2026 | $621,200 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322 | DEKALB | USA | R01AI136581 | Lentivirus Replication Strategy and Pathogenesis | 000 | 9 | NIH | 4/17/2026 | $436,338 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322 | DEKALB | USA | R01CA262123 | Personalized vaccine immunotherapy in combination with anti-PD 1 antibody for recurrent or metastatic squamous cell carcinoma of the head and neck | 000 | 4 | NIH | 4/17/2026 | $619,091 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322 | DEKALB | USA | F31NS135955 | Assessing the Contribution of Cortical Hyperactivity to ALS Phenotypes in a Human-Derived Motor System | 001 | 3 | NIH | 4/15/2026 | $576 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322 | DEKALB | USA | R01HL161366 | Reverse Tissue-Manufacturing of the Multicellular Sinoatrial Node Organoids | 000 | 4 | NIH | 3/19/2026 | $566,845 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322 | DEKALB | USA | R01HL171735 | Advancing Symptom Science and Management in Cystic Fibrosis: Biological, Social, and Clinical Mechanisms | 001 | 3 | NIH | 3/19/2026 | $19,368 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322 | DEKALB | USA | F31AI189080 | Mechanism of Antibiotic Substrate Translocation in Bacterial RND Family Efflux Pumps | 000 | 1 | NIH | 4/17/2026 | $55,114 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322 | DEKALB | USA | R01CA261887 | Outcomes in AYA survivors of pediatric medulloblastoma. | 001 | 5 | NIH | 4/17/2026 | $70,459 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322 | DEKALB | USA | F31NS147773 | Functional and biochemical analysis of RNA exosome variants linked to neurological disorders | 002 | 1 | NIH | 4/15/2026 | $576 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | U24NS107234 | NIH StrokeNet- Regional Coordinating Stroke Centers for year 2023 | 000 | 8 | NIH | 3/19/2026 | $403,365 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322 | DEKALB | USA | R01CA275964 | Targeting leukemic stem cells in acute myeloid leukemia | 001 | 4 | NIH | 4/16/2026 | $42,215 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322 | DEKALB | USA | R01MH128705 | PET ligand discovery for arginine vasopressin | 000 | 5 | NIH | 4/17/2026 | $1,159,299 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322 | DEKALB | USA | R21NS146918 | NMDA receptor regulation of rapid scaling and spinal excitability in fragile X syndrome. | 000 | 1 | NIH | 5/12/2026 | $234,750 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322 | DEKALB | USA | R37CA297078 | Targeting non-genetic and genetic mechanisms to overcome drug resistance in acute myeloid leukemia | 000 | 1 | NIH | 4/28/2026 | $639,859 |
|
